Search Results

There are 57530 results for: content related to: The Nephroprotective Properties of Recombinant Human Erythropoietin in Kidney Transplantation: Experimental Facts and Clinical Proofs

  1. You have free access to this content
    Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response

    Journal of Internal Medicine

    Volume 264, Issue 5, November 2008, Pages: 405–432, M. Brines and A. Cerami

    Version of Record online : 8 OCT 2008, DOI: 10.1111/j.1365-2796.2008.02024.x

  2. You have free access to this content
    Organ-Protective and Immunomodulatory Effects of Erythropoietin – An Update on Recent Clinical Trials

    Basic & Clinical Pharmacology & Toxicology

    Volume 110, Issue 2, February 2012, Pages: 113–121, Christoffer Sølling

    Version of Record online : 9 NOV 2011, DOI: 10.1111/j.1742-7843.2011.00820.x

  3. The Role of Protein Excipient in Driving Antibody Responses to Erythropoietin

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 12, December 2015, Pages: 4041–4055, Merry Christie, David Peritt, Raul M. Torres, Theodore W. Randolph and John F. Carpenter

    Version of Record online : 16 SEP 2015, DOI: 10.1002/jps.24639

  4. Neuroprotective effects of erythropoietin posttreatment against kainate-induced excitotoxicity in mixed spinal cultures

    Journal of Neuroscience Research

    Volume 87, Issue 1, January 2009, Pages: 150–163, Jong Yoon Yoo, You Jin Won, Jong Hwan Lee, Jong Uk Kim, In Young Sung, Seung Jun Hwang, Mi Jung Kim and Hea Nam Hong

    Version of Record online : 18 AUG 2008, DOI: 10.1002/jnr.21832

  5. You have full text access to this Open Access content
    Plant recombinant erythropoietin attenuates inflammatory kidney cell injury

    Plant Biotechnology Journal

    Volume 7, Issue 2, February 2009, Pages: 183–199, Andrew J. Conley, Kanishka Mohib, Anthony M. Jevnikar and Jim E. Brandle

    Version of Record online : 28 NOV 2008, DOI: 10.1111/j.1467-7652.2008.00389.x

  6. Isolation and characterization of a subset of erythropoietin glycoforms with cytoprotective but minimal erythropoietic activity

    Biotechnology Progress

    Volume 27, Issue 4, July/August 2011, Pages: 1018–1028, Mónica Mattio, Natalia Ceaglio, Marcos Oggero, Norma Perotti, Ignacio Amadeo, Gustavo Orozco, Guillermina Forno, Ricardo Kratje and Marina Etcheverrigaray

    Version of Record online : 23 MAY 2011, DOI: 10.1002/btpr.633

  7. Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury


    Volume 51, Issue 4, September 2005, Pages: 254–265, Xiaoqing Li, Steven L. Gonias and W. Marie Campana

    Version of Record online : 5 APR 2005, DOI: 10.1002/glia.20202

  8. You have free access to this content
    Erythropoietin modulates intracellular calcium in a human neuroblastoma cell line

    The Journal of Physiology

    Volume 516, Issue 2, April 1999, Pages: 343–352, Roberta Assandri, Marcel Egger, Max Gassmann, Ernst Niggli, Christian Bauer, Ian Forster and Agnes Görlach

    Version of Record online : 8 SEP 2004, DOI: 10.1111/j.1469-7793.1999.0343v.x

  9. You have free access to this content
    Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cells

    International Journal of Cancer

    Volume 122, Issue 2, 15 January 2008, Pages: 274–280, Jee-Yeong Jeong, Laurie Feldman, Peter Solar, Jolanta Szenajch and Arthur J. Sytkowski

    Version of Record online : 24 SEP 2007, DOI: 10.1002/ijc.23068

  10. You have free access to this content
    Activation of mitochondrial function and Hb expression in non-haematopoietic cells by an EPO inducer ameliorates ischaemic diseases in mice

    British Journal of Pharmacology

    Volume 169, Issue 7, August 2013, Pages: 1461–1476, Pei-Lun Hsu, Lin-Yea Horng, Kang-Yung Peng, Chia-Ling Wu, Hui-Ching Sung and Rong-Tsun Wu

    Version of Record online : 12 JUL 2013, DOI: 10.1111/bph.12197

  11. Blunting effect of hypoxia on the proliferation and differentiation of human primary and rat L6 myoblasts is not counteracted by Epo

    Cell Proliferation

    Volume 43, Issue 1, February 2010, Pages: 1–8, T. Launay, L. Hagström, S. Lottin-Divoux, D. Marchant, P. Quidu, F. Favret, A. Duvallet, T. Darribère, J. P. Richalet and M. Beaudry

    Version of Record online : 27 DEC 2009, DOI: 10.1111/j.1365-2184.2009.00648.x

  12. The impact of sialic acids on the pharmacokinetics of a PEGylated erythropoietin

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 12, December 2012, Pages: 4414–4418, Liming Liu, Huijuan Li, Stephen R. Hamilton, Sujatha Gomathinayagam, William J. Rayfield, Marc van Maanen, Kuo-Chang Yin, Laura Hong and Thomayant Prueksaritanont

    Version of Record online : 16 SEP 2012, DOI: 10.1002/jps.23320

  13. Erythropoietin Receptor Is Expressed on Human Peripheral Blood T and B Lymphocytes and Monocytes and Is Modulated by Recombinant Human Erythropoietin Treatment

    Artificial Organs

    Volume 34, Issue 8, August 2010, Pages: 654–662, Katarzyna A. Lisowska, Alicja Dębska-Ślizień, Ewa Bryl, Bolesław Rutkowski and Jacek M. Witkowski

    Version of Record online : 31 MAY 2010, DOI: 10.1111/j.1525-1594.2009.00948.x

  14. You have full text access to this OnlineOpen article
    Expression of functionally active sialylated human erythropoietin in plants

    Biotechnology Journal

    Volume 8, Issue 3, March 2013, Pages: 371–382, Jakub Jez, Alexandra Castilho, Josephine Grass, Karola Vorauer-Uhl, Thomas Sterovsky, Friedrich Altmann and Prof. Herta Steinkellner

    Version of Record online : 4 MAR 2013, DOI: 10.1002/biot.201200363

  15. Erythropoietin and ischemic conditioning – why two good things may be bad

    Acta Paediatrica

    Volume 96, Issue 6, June 2007, Pages: 787–789, Christoph Bührer, Ursula Felderhoff-Mueser and Sven Wellmann

    Version of Record online : 24 MAY 2007, DOI: 10.1111/j.1651-2227.2007.00335.x

  16. You have full text access to this Open Access content
    High-level expression of secreted complex glycosylated recombinant human erythropoietin in the Physcomitrella Δ-fuc-t Δ-xyl-t mutant

    Plant Biotechnology Journal

    Volume 5, Issue 3, May 2007, Pages: 389–401, Andreas Weise, Friedrich Altmann, Marta Rodriguez-Franco, Eric R. Sjoberg, Wolfgang Bäumer, Heike Launhardt, Manfred Kietzmann and Gilbert Gorr

    Version of Record online : 15 MAR 2007, DOI: 10.1111/j.1467-7652.2007.00248.x

  17. Erythropoietin protects against apoptosis and increases expression of non-neuronal cell markers in the hypoxia-injured developing brain

    The Journal of Pathology

    Volume 224, Issue 1, May 2011, Pages: 101–109, Miko Yamada, Christopher Burke, Paul Colditz, David W Johnson and Glenda C Gobe

    Version of Record online : 14 MAR 2011, DOI: 10.1002/path.2862

  18. You have free access to this content
    Cochrane review: Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants

    Evidence-Based Child Health: A Cochrane Review Journal

    Volume 5, Issue 1, March 2010, Pages: 151–238, Arne Ohlsson and Sanjay M Aher

    Version of Record online : 18 JUN 2010, DOI: 10.1002/ebch.521

  19. You have free access to this content
    Treating patients with schizophrenia deficit with erythropoietin?

    Psychiatry and Clinical Neurosciences

    Volume 66, Issue 5, August 2012, Pages: 375–382, Guillaume Fond, Alexandra Macgregor, Jérome Attal, Aurore Larue, Marie Brittner, Deborah Ducasse and Delphine Capdevielle

    Version of Record online : 21 JUN 2012, DOI: 10.1111/j.1440-1819.2012.02359.x

  20. Differences in sialic acid O-acetylation between human urinary and recombinant erythropoietins: a possible mass spectrometric marker for doping control

    Drug Testing and Analysis

    Volume 5, Issue 11-12, November-December 2013, Pages: 877–889, Christian Reichel

    Version of Record online : 6 NOV 2013, DOI: 10.1002/dta.1563